Following two decades at Kendall, Tyco Healthcare and Covidien, Richard Meelia rides off into the sunset at COV.
Richard Meelia, the CEO who led Covidien plc (NYSE:COV) in its various incarnations for more than two decades will hand over the keys to the corner officer to José (Joe) Almeida today without fanfare.
Meelia, 62, was named president & CEO of Covidien in June 2007, after it was spun out of the disintegrating Tyco International. He was elected chairman in October 2008 and has been with the company in its different forms for 20 years.
Meelia was also president at Kendall Healthcare Products Co., which was spun into Tyco Healthcare and then Covidien, growing the business from $600 million to more than $10.4 billion in 2010.
Meelia will stay on as non-executive chairman of Covidien's board for a transition period of up to a year after his retirement, according to a press release
In a statement sent to MassDevice Meelia said he had every confidence in his successor.
"Joe Almeida is a great leader who has proven his mettle over many years, most recently in his outstanding direction of our Medical Devices segment," he said. "As I prepare to transition my responsibilities to Joe, I have every confidence that, backed by our superb global workforce, he will lead our Company on to even better performance and greater success in the years to come."
Teleflex expands a Class I recall for Maquet Servo 163 humidifiers and beats expectations with its...
Nikon, best known for its cameras, moves into medtech with Optos buy
A single human error in India prompts GE Healthcare to issue a warning on 30 years worth of its MRI...
Staar Surgical posts net losses for the 4th quarter and 2014 but comes close to meeting earnings...